Previous LKSIoV Funding Programs
Rapid Response Grants
| INVESTIGATOR(S) | AMOUNT |
|---|---|
| Tom Hobman (Zika Virus) | $50,000 |
| Michael Houghton & Lorne Tyrrell (XMRV Study) | $50,000 |
| Luis Schang (Antiviral – Helmholtz) | $50,000 |
| TOTAL | $150,000 |
Translational Research Grants 2017
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Troy Baldwin | $50,000 | Regulation of Nur77 transcriptional activity for therapeutic purposes |
| Jim Smiley | $50,000 | Harnessing the cGAS/STING pathway to enhance vaccination and viral oncolytics |
| Richard Wozniak | $50,000 | Development of nanobodies for analysis of the zika virus life cycle |
| Stephanie Yanow | $50,000 | Cross-species epitopes as candidate vaccines against placental malaria |
| TOTAL | $200,000 |
Translational Research Grants 2016
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Matthias Götte | $100,000 | Discovery of CMV and EBV terminase inhibitors |
| Katharine Magor | $50,000 | Generation of influenza A resistant chickens expressing RIG-I |
| TOTAL | $150,000 |
Translational Research Grants 2015
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Troy Baldwin, Stephanie Yanow, Michael Hawkes and Michael Good | $100,000 | A mouse model for pre-clinical evaluation of vaccines against human malaria |
| Edan Foley | $100,000 | Translational characterization of novel TNF pathway inhibitors |
| Maya Shmulevitz | $100,000 | In vivo validation of novel reovirus variants for superior oncolytic therapy |
| TOTAL | $300,000 |
Translational Research Grants 2014
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Khaled Barakat | $50,000 | Computer-assisted search for HCV treatments targeting a novel binding site in the NS5A protein |
| Chris Bleackley | $100,000 | Development of a novel inhibitor of granzyme B as a therapeutic |
| David Marchant | $92,826 | Identification of nucleoside analogues as candidate drugs to prevent and treat RSV infection |
| Andrew Mason | $50,000 | Diagnostic assays to detect immune responses to human betaretrovirus |
| Stefan Pukatzki | $99,350 | The type VI secretion system of Vibrio cholera as a target for a new class of antimicrobials |
| Luis Schang | $100,000 | Development of inhibitors of infectivity of enveloped and non-enveloped viruses |
| Tom Hobman and Khaled Barakat | $100,000 | Developing a novel combination therapy for Dengue virus (DENV) infection |
| TOTAL | $592,176 |
Translational Research Grants 2013
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Michele Barry and Patrick MacDonald | $50,000 | Preventing human islet death and dysfunction by viral encoded proteins |
| Luis Schang | $100,000 | Development of novel antivirals - formulation and analyses |
| Edan Foley | $100,000 | A high-content screen for pharmacological inhibitors of SCF[betaTrCP] |
| Norm Kneteman and Donna Douglas | $50,000 | Development of an immunocompetent mouse model of HCV infection |
| TOTAL | $300,000 |
Translational Research Grants 2012
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Deborah Burshtyn | $50,000 | Investigating LILRB1 genotype as a biomarker of post transplant susceptibility to CMV disease |
| David Evans, Mary Hitt and Ron Moore | $100,000 | Development of novel oncolytic poxviruses |
| Kevin Kane | $100,000 | Cytotoxic T cell epitopes in hepatocellular carcinoma |
| Deepali Kumar | $100,000 | Modulation of interferon lambda signaling to regulate innate and adaptive immune response during vaccination |
| TOTAL | $350,000 |